نمایش پرونده ساده آیتم

dc.contributor.authorMohaddes, G
dc.contributor.authorAbdolalizadeh, J
dc.contributor.authorBabri, S
dc.contributor.authorHossienzadeh, F
dc.date.accessioned2018-08-26T08:56:17Z
dc.date.available2018-08-26T08:56:17Z
dc.date.issued2017
dc.identifier10.1113/EP086068
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54422
dc.description.abstractNew Findings: What is the central question of this study? Is an anti-oedematous effect of ghrelin associated with increased expression of tight junction proteins in the hypoxic brain? What is the main finding and its importance? We showed that injection of ghrelin during acute and chronic systemic hypoxia is associated with increased expression of tight junction proteins and protection of the blood-brain barrier. Ghrelin appears to be a new therapeutic strategy for protection of the blood-brain barrier from disruption and prevention of brain oedema in hypoxic conditions. The blood-brain barrier, which serves to protect the homeostasis of the CNS, is formed by tight junction proteins. Several studies have indicated that systemic hypoxia leads to cerebral oedema through disruption of tight junction proteins, such as occludin and zonula occludens-1 (ZO-1). According to our previous studies, ghrelin attenuates cerebral oedema in the hypoxic brain. However, the mechanism is not completely understood. The present study was designed to determine the effect of ghrelin on occludin and ZO-1 in the hypoxic brain. Adult male Wistar rats were divided into acute and chronic control, acute or chronic hypoxia, and ghrelin-treated acute or chronic hypoxia groups. Hypoxic groups were kept in a hypoxic chamber (10-11% O2) for 2 (acute) or 10 days (chronic). Effects of ghrelin on occludin and ZO-1 protein levels were assessed using Western blotting. Western blot analysis revealed that the protein expression of ZO-1 and occludin decreased significantly in acute and chronic hypoxia. Ghrelin significantly increased ZO-1 protein expression in both acute and chronic hypoxia (Pآ <آ 0.05). Ghrelin also increased occludin protein expression in chronic hypoxia (Pآ <آ 0.05) but did not effectively change it in acute hypoxia. Our data showed that ghrelin injection maintains occludin and ZO-1 tight junction proteins, which may improve the integrity of the blood-brain barrier in hypoxic conditions. é 2017 The Authors. Experimental Physiology é 2017 The Physiological Society
dc.language.isoEnglish
dc.relation.ispartofExperimental Physiology
dc.subjectghrelin
dc.subjectoccludin
dc.subjectoxygen
dc.subjectprotein ZO1
dc.subjectghrelin
dc.subjectmembrane protein
dc.subjectoccludin
dc.subjectacute disease
dc.subjectadult
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectArticle
dc.subjectblood brain barrier
dc.subjectbrain hypoxia
dc.subjectchronic disease
dc.subjectcontrolled study
dc.subjectmale
dc.subjectnonhuman
dc.subjectprotein expression
dc.subjectrat
dc.subjecttight junction
dc.subjectWestern blotting
dc.subjectanimal
dc.subjectblood brain barrier
dc.subjectbrain
dc.subjectdrug effects
dc.subjecthypoxia
dc.subjectmetabolism
dc.subjectWistar rat
dc.subjectAnimals
dc.subjectBlood-Brain Barrier
dc.subjectBrain
dc.subjectGhrelin
dc.subjectHypoxia
dc.subjectMale
dc.subjectMembrane Proteins
dc.subjectOccludin
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectTight Junctions
dc.titleGhrelin ameliorates blood-brain barrier disruption during systemic hypoxia
dc.typeArticle
dc.citation.volume102
dc.citation.issue3
dc.citation.spage376
dc.citation.epage382
dc.citation.indexScopus
dc.identifier.DOI10.1113/EP086068


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم